Cytokinetics Inc Earnings

Cytokinetics Inc’s revenue jumped 4.89% since last year same period to $17.76Mn in the Q4 2025. On a quarterly growth basis, Cytokinetics Inc has generated 817.1% jump in its revenue since last 3-months.

Cytokinetics Inc’s net profit fell -22% since last year same period to $-183.03Mn in the Q4 2025. On a quarterly growth basis, Cytokinetics Inc has generated 40.22% jump in its net profits since last 3-months.

Cytokinetics Inc’s net profit margin fell -16.31% since last year same period to -1030.87% in the Q4 2025. On a quarterly growth basis, Cytokinetics Inc has generated 93.48% jump in its net profit margins since last 3-months.

Cytokinetics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.61 - a -3.21% fall from last quarter’s estimates.

Cytokinetics Inc’s earning per share (EPS) estimates for the current year stand at -1.61.

Cytokinetics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2026. This indicates that the Cytokinetics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.